120 related articles for article (PubMed ID: 20974479)
1. Intrinsic phospholipase A2 activity of adeno-associated virus is involved in endosomal escape of incoming particles.
Stahnke S; Lux K; Uhrig S; Kreppel F; Hösel M; Coutelle O; Ogris M; Hallek M; Büning H
Virology; 2011 Jan; 409(1):77-83. PubMed ID: 20974479
[TBL] [Abstract][Full Text] [Related]
2. Cross-dressing the virion: the transcapsidation of adeno-associated virus serotypes functionally defines subgroups.
Rabinowitz JE; Bowles DE; Faust SM; Ledford JG; Cunningham SE; Samulski RJ
J Virol; 2004 May; 78(9):4421-32. PubMed ID: 15078923
[TBL] [Abstract][Full Text] [Related]
3. Adeno-associated virus type 2 VP2 capsid protein is nonessential and can tolerate large peptide insertions at its N terminus.
Warrington KH; Gorbatyuk OS; Harrison JK; Opie SR; Zolotukhin S; Muzyczka N
J Virol; 2004 Jun; 78(12):6595-609. PubMed ID: 15163751
[TBL] [Abstract][Full Text] [Related]
4. Heparin binding directs activation of T cells against adeno-associated virus serotype 2 capsid.
Vandenberghe LH; Wang L; Somanathan S; Zhi Y; Figueredo J; Calcedo R; Sanmiguel J; Desai RA; Chen CS; Johnston J; Grant RL; Gao G; Wilson JM
Nat Med; 2006 Aug; 12(8):967-71. PubMed ID: 16845388
[TBL] [Abstract][Full Text] [Related]
5. Surface-exposed adeno-associated virus Vp1-NLS capsid fusion protein rescues infectivity of noninfectious wild-type Vp2/Vp3 and Vp3-only capsids but not that of fivefold pore mutant virions.
Grieger JC; Johnson JS; Gurda-Whitaker B; Agbandje-McKenna M; Samulski RJ
J Virol; 2007 Aug; 81(15):7833-43. PubMed ID: 17507473
[TBL] [Abstract][Full Text] [Related]
6. Insertional mutagenesis of AAV2 capsid and the production of recombinant virus.
Rabinowitz JE; Xiao W; Samulski RJ
Virology; 1999 Dec; 265(2):274-85. PubMed ID: 10600599
[TBL] [Abstract][Full Text] [Related]
7. The VP1 capsid protein of adeno-associated virus type 2 is carrying a phospholipase A2 domain required for virus infectivity.
Girod A; Wobus CE; Zádori Z; Ried M; Leike K; Tijssen P; Kleinschmidt JA; Hallek M
J Gen Virol; 2002 May; 83(Pt 5):973-978. PubMed ID: 11961250
[TBL] [Abstract][Full Text] [Related]
8. Adeno-associated virus capsid antigen presentation is dependent on endosomal escape.
Li C; He Y; Nicolson S; Hirsch M; Weinberg MS; Zhang P; Kafri T; Samulski RJ
J Clin Invest; 2013 Mar; 123(3):1390-401. PubMed ID: 23454772
[TBL] [Abstract][Full Text] [Related]
9. Chromosomal latency and expression at map unit 96 of a wild-type plus adeno-associated virus (AAV)/Neo vector and identification of p81, a new AAV transcriptional promoter.
Hermonat PL; Santin AD; De Greve J; De Rijcke M; Bishop BM; Han L; Mane M; Kokorina N
J Hum Virol; 1999; 2(6):359-68. PubMed ID: 10774553
[TBL] [Abstract][Full Text] [Related]
10. Adeno-associated virus type 2 capsids with externalized VP1/VP2 trafficking domains are generated prior to passage through the cytoplasm and are maintained until uncoating occurs in the nucleus.
Sonntag F; Bleker S; Leuchs B; Fischer R; Kleinschmidt JA
J Virol; 2006 Nov; 80(22):11040-54. PubMed ID: 16956943
[TBL] [Abstract][Full Text] [Related]
11. Altering AAV tropism with mosaic viral capsids.
Gigout L; Rebollo P; Clement N; Warrington KH; Muzyczka N; Linden RM; Weber T
Mol Ther; 2005 Jun; 11(6):856-65. PubMed ID: 15922956
[TBL] [Abstract][Full Text] [Related]
12. Serotype-specific replicating AAV helper constructs increase recombinant AAV type 2 vector production.
Li C; Samulski RJ
Virology; 2005 Apr; 335(1):10-21. PubMed ID: 15823602
[TBL] [Abstract][Full Text] [Related]
13. Endocytic processing of adeno-associated virus type 8 vectors for transduction of target cells.
Liu Y; Joo KI; Wang P
Gene Ther; 2013 Mar; 20(3):308-17. PubMed ID: 22622241
[TBL] [Abstract][Full Text] [Related]
14. The Assembly-Activating Protein Promotes Stability and Interactions between AAV's Viral Proteins to Nucleate Capsid Assembly.
Maurer AC; Pacouret S; Cepeda Diaz AK; Blake J; Andres-Mateos E; Vandenberghe LH
Cell Rep; 2018 May; 23(6):1817-1830. PubMed ID: 29742436
[TBL] [Abstract][Full Text] [Related]
15. Two novel adeno-associated viruses from cynomolgus monkey: pseudotyping characterization of capsid protein.
Mori S; Wang L; Takeuchi T; Kanda T
Virology; 2004 Dec; 330(2):375-83. PubMed ID: 15567432
[TBL] [Abstract][Full Text] [Related]
16. Adeno-associated virus capsid serotype identification: Analytical methods development and application.
Van Vliet K; Mohiuddin Y; McClung S; Blouin V; Rolling F; Moullier P; Agbandje-McKenna M; Snyder RO
J Virol Methods; 2009 Aug; 159(2):167-77. PubMed ID: 19447508
[TBL] [Abstract][Full Text] [Related]
17. Mutational analysis of narrow pores at the fivefold symmetry axes of adeno-associated virus type 2 capsids reveals a dual role in genome packaging and activation of phospholipase A2 activity.
Bleker S; Sonntag F; Kleinschmidt JA
J Virol; 2005 Feb; 79(4):2528-40. PubMed ID: 15681453
[TBL] [Abstract][Full Text] [Related]
18. Engineering adeno-associated virus serotype 2-based targeting vectors using a new insertion site-position 453-and single point mutations.
Boucas J; Lux K; Huber A; Schievenbusch S; von Freyend MJ; Perabo L; Quadt-Humme S; Odenthal M; Hallek M; Büning H
J Gene Med; 2009 Dec; 11(12):1103-13. PubMed ID: 19777441
[TBL] [Abstract][Full Text] [Related]
19. Adeno-associated virus vectors serotyped with AAV8 capsid are more efficient than AAV-1 or -2 serotypes for widespread gene delivery to the neonatal mouse brain.
Broekman ML; Comer LA; Hyman BT; Sena-Esteves M
Neuroscience; 2006; 138(2):501-10. PubMed ID: 16414198
[TBL] [Abstract][Full Text] [Related]
20. Genetic modifications of the adeno-associated virus type 2 capsid reduce the affinity and the neutralizing effects of human serum antibodies.
Huttner NA; Girod A; Perabo L; Edbauer D; Kleinschmidt JA; Büning H; Hallek M
Gene Ther; 2003 Dec; 10(26):2139-47. PubMed ID: 14625569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
